Your SlideShare is downloading. ×
0
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Acid Reflux and GERD
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Acid Reflux and GERD

492

Published on

A new compound for GERD/Acid reflux treatment. …

A new compound for GERD/Acid reflux treatment.
www.nanomeda.com

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
492
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Do you want to go with this PPI Drugs? Big Problem? • PPI drugs proven to cause vitamin B12 deficiency • Tuesday, December 17, 2013 by: PF Louis Tags: PPI drugs, B12 deficiency, vitamin supplements No! Wait! We have an option for you. 100% safe and effective solution for GERD/Acid Reflux
  • 2. Big Problem • According to a new study in the Journal of the American Medical Association, proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs) suppress gastric acid production, which can mean that the Vitamin B12 in food is not properly absorbed into the body. Vitamin B12 deficiency is linked to serious health complications, such as anemia, nerve damage, and dementia • The most commonly used PPIs are Prilosec, Prevacid, Nexium, Protonix, and Aciphex. The most popular H2RAs include Zantac, Pepcid, and Tagamet.
  • 3. MegnaCur-Discovery A newly discovered Compound for Acid Reflux/GERD
  • 4. GERD/Acid Reflux
  • 5. Market Size • In recent years, GI prescriptions have remained one of the world’s largest therapeutic markets, with sales of more than $20 billion • Given the large public need and the propensity for high returns, the gastroenterology market is set to expand. As an increasing pool of smaller specialty pharmaceutical players recognize the need and importance of developing innovative treatments to restore normal function of the GI system and improve patients’ quality of life, the doors to improved GI health are opening, and opportunity
  • 6. Established • • • • • • • • • A newly discovered compound Proof of concept No generic cliff Patent protection Pilot scale production Raw material qualification Manufacturing and QC protocols Machinery identified Formulation
  • 7. Product • • • • • Capsule Tablet Syrup Soft drink Chewing gum Ready to Launch
  • 8. Next • • • • • cGMP manufacturing Preclinicals NDA Clinical trials Market/Partners/Exit
  • 9. Funds • • • • $3million 1st round 3-5 years for exit and product launch We provide patent protection Direct investment on clinical trials
  • 10. Contact To Join Us Mewa Singh, PhD mewasinghsandhu@hotmail.com 609-902-7128 www.nanomeda.com www.nanosgroup.com Opportunity for $20Billion Market
  • 11. MegnaCur-A new compound for GERD/Acid Reflux

×